Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**5-methoxy-N,N-diisopropyltryptamine** (commonly known as 5-MeO-DIPT, "foxy," or "foxy methoxy") is a synthetic psychedelic drug belonging to the tryptamine class. It is structurally related to other hallucinogenic tryptamines such as psilocybin, psilocin, and DMT. The compound acts primarily as a hallucinogen and has been widely abused for its psychoactive effects since the late 1990s[1][2][3][4]. Pharmacologically, preclinical studies indicate that it functions as a potent serotonin transporter (SERT) inhibitor and displays high affinity at serotonin receptors including the serotonin 5-HT1A, 5-HT2A, and 5-HT2C subtypes[5]. Its hallucinogenic activity appears to be mediated through agonism of these receptors. In animal models and humans, it produces behavioral effects similar to those of LSD and DOM[4][7]. Effects typically begin within about half an hour after ingestion, peak at around one hour, and last three to six hours; they include hallucinations, sensory distortion (notably sound), emotional enhancement or lability, nausea, muscular hyperreflexia, pupil dilation, relaxation or anxiety[4][7]. There are no accepted medical uses for this substance in the United States; it is classified as a Schedule I controlled substance due to its high potential for abuse and lack of recognized safety under medical supervision[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-methoxy-N,N-diisopropyltryptamine.